A 7-Week, Randomized, Double-Blind Trial of Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.v67n0703
Authors: Eileen B. Brown, Susan L. McElroy, Paul E. Keck, Ahmed Deldar, David H. Adams, Mauricio Tohen, Douglas J. Williamson
Institution: Eli Lilly (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: bipolar I depression, olanzapine-fluoxetine combination, lamotrigine, atypical antipsychotics, antidepressant efficacy, treatment response time, adverse events, weight gain, tolerability, mood stabilizers, Young Mania Rating Scale, Montgomery-Asberg Depression Rating Scale, clinical global impression
Open Access status: closed
OpenAlex ID: W2011797837
